8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glycated hemoglobin A1c (HbA1c) is routinely used to diagnose and monitor type 2 diabetes mellitus (T2DM) in cirrhotic patients. Remarkably, HbA1c may be falsely low in such patients.

          Related collections

          Author and article information

          Journal
          Digestive diseases and sciences
          Springer Science and Business Media LLC
          1573-2568
          0163-2116
          December 2018
          : 63
          : 12
          Affiliations
          [1 ] Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
          [2 ] Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
          [3 ] Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, CA, USA.
          [4 ] Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. aduarterojo@uams.edu.
          Article
          10.1007/s10620-018-5265-3
          10.1007/s10620-018-5265-3
          30159733
          f6e89018-0a5c-4054-b794-459feef9e388
          History

          Oral glucose tolerance test,Fasting glucose,Continuous glucose monitoring,Prediabetes,HbA1c

          Comments

          Comment on this article